SNMMI

JNM CE/SAM (August 2017): 177Lu-PSMA Radioligand Therapy for Prostate Cancer

JNM, August 2017, Volume 58, Number 8

Release Date: 8/1/2017
Expiration Date: 8/31/2020

SNMMI Members: Free
Non-Members: $69.00

Continuing Education Credit Information

ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 2.0 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits^TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Objectives

On successful completion of this activity, participants should be able to…
1. Identify potential candidates for 177Lu-PSMA RLT.
2. Explain the concept and clinical workflow of PSMA-directed RLT.
3. Summarize prostate-specific antigen response rates and common adverse events after 177LuPSMA RLT.

Target Audience

This MOC Part II activity contains information of value to nuclear medicine physicians, oncologists, and nuclear medicine technologists.

Author

Authors Wolfgang P. Fendler1,2, Kambiz Rahbar3, Ken Herrmann1,4, Clemens Kratochwil5, and Matthias Eiber1,6

1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; 2Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Munich, Germany; 3Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany; 4Department of Nuclear Medicine, Medical Faculty, University Hospital Essen, Essen, Germany; 5Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany; and 6Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany

Disclosures:

Name	Role	Disclosure
Wolfgang P. Fendler, MD	Author	Wolfgang Fendler is a consultant/advisor to Ipsen.
Kambiz Rahbar, MD	Author	University Hospital Muenster has received consulting fees from ABX Advanced Biochemical Compounds for Kambiz Rahbar.
Ken Herrmann, MD	Author	Nothing to Disclose
Clemens Kratochwil, MD	Author	Nothing to Disclose
Matthias Eiber, MD, PhD	Author	Nothing to Disclose
Todd E. Peterson, PhD	Chair, Publications Committee	Nothing to Disclose
Johannes Czernin, MD	Editor-In-Chief	Nothing to Disclose
Heiko Schoder, MD	Associate Editor, Continuing Education	Nothing to Disclose
Arnold M. Strashun, MD	Chair, Continuing Education Committee	Nothing to Disclose
Steve Larson, MD	JNM Reviewer	Nothing to Disclose
Peter Choyke, MD, FACR	JNM Reviewer	Nothing to Disclose
Susan Alexander	SNMMI Staff, Publications	Nothing to Disclose
Caroline Krystek	SNMMI Staff, Education	Nothing to Disclose
No Commercial Support was received for this activity

The following members of the Publications Committee have no relevant financial relationships to disclose.
Danny A. Basso, CNMT, NCT	Michael M. Graham, PhD, MD	Heinrich R. Schelbert, MD, PhD	Henry F. VanBrocklin, PhD
Paige B. Bennett, MD	Hossein Jadvar, MD, PhD, MPH, MBA	Heiko Schoder, MD	Harvey A. Ziessman, MD
Johannes Czernin, MD	Steven M. Larson, MD, FACNM	Mathew L. Thakur, PhD	Rebecca Maxey - SNMMI Staff
Stanley J. Goldsmith, MD	Rustain L. Morgan, MD	Kathy S. Thomas, MHA,CNMT,PET

In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the planners and authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

The JNM editors, reviewers and SNMMI Staff have indicated that they do not have a financial interest, arrangement or affiliation with any commercial organization that may have a direct or indirect interest in the content of manuscripts submitted to JNM.

Contact Information

For questions please contact Lisa Dickinson, Associate Director of Education at ldickinson@snmmi.org or 703-652-6783.

Disclosures:

Name	Role	Disclosure
Wolfgang P. Fendler, MD	Author	Wolfgang Fendler is a consultant/advisor to Ipsen.
Kambiz Rahbar, MD	Author	University Hospital Muenster has received consulting fees from ABX Advanced Biochemical Compounds for Kambiz Rahbar.
Ken Herrmann, MD	Author	Nothing to Disclose
Clemens Kratochwil, MD	Author	Nothing to Disclose
Matthias Eiber, MD, PhD	Author	Nothing to Disclose
Todd E. Peterson, PhD	Chair, Publications Committee	Nothing to Disclose
Johannes Czernin, MD	Editor-In-Chief	Nothing to Disclose
Heiko Schoder, MD	Associate Editor, Continuing Education	Nothing to Disclose
Arnold M. Strashun, MD	Chair, Continuing Education Committee	Nothing to Disclose
Steve Larson, MD	JNM Reviewer	Nothing to Disclose
Peter Choyke, MD, FACR	JNM Reviewer	Nothing to Disclose
Susan Alexander	SNMMI Staff, Publications	Nothing to Disclose
Caroline Krystek	SNMMI Staff, Education	Nothing to Disclose
No Commercial Support was received for this activity

The following members of the Publications Committee have no relevant financial relationships to disclose.
Danny A. Basso, CNMT, NCT	Michael M. Graham, PhD, MD	Heinrich R. Schelbert, MD, PhD	Henry F. VanBrocklin, PhD
Paige B. Bennett, MD	Hossein Jadvar, MD, PhD, MPH, MBA	Heiko Schoder, MD	Harvey A. Ziessman, MD
Johannes Czernin, MD	Steven M. Larson, MD, FACNM	Mathew L. Thakur, PhD	Rebecca Maxey - SNMMI Staff
Stanley J. Goldsmith, MD	Rustain L. Morgan, MD	Kathy S. Thomas, MHA,CNMT,PET